For General medical information or questions about a specific medical condition or product, please consult your healthcare provider.
Crescent Pharma is part of Crescent Pharmaceutical Group, an independent pharmaceutical group developing, manufacturing and supplying generic medicines through UK operations, global in-house capabilities and carefully managed pharmaceutical partnerships.
Crescent Pharma operates from offices, manufacturing sites and distribution centres across the UK, with additional R&D and international operations supporting our global supply network.
The expiry date shows the period during which the medicine should be used. Where an expiry is shown as a month and year, the medicine should not be used after the last day of that month. Always follow the information provided on the medicine packaging and Patient Information Leaflet.
A full list of active ingredients and other ingredients can be found in the Patient Information Leaflet supplied with the medicine. If you do not have the leaflet or packaging, speak to your pharmacist or healthcare professional or contact Crescent Medical Information.
Information about your medicine and its packaging can be found on the product packaging and in the Patient Information Leaflet. If you have a question about a Crescent product or its packaging, please contact our Medical Information team.
Colours are carefully selected to help distinguish different medicines and strengths, reducing the risk of confusion during dispensing.
Recycling options vary according to the packaging material and local recycling arrangements. Do not dispose of unused or unwanted medicines in household waste or wastewater. Take unwanted medicines to a pharmacy for appropriate disposal. Your pharmacist can also advise you about disposal of medicine packaging.
If you think you have experienced a side effect from a Crescent medicine, speak to your doctor, pharmacist or other healthcare professional for medical advice. You can also report a suspected side effect directly to Crescent through our Report a Side Effect page.
Suspected side effects can also be reported through the MHRA Yellow Card scheme.
If you have a concern about the quality, packaging, appearance or condition of a Crescent medicine, please contact Crescent Customer Services. Where possible, retain the medicine and packaging and provide the product name, strength, batch number and expiry date when contacting us.
If your concern relates to a suspected side effect, please use our Report a Side Effect service instead.
Crescent supplies medicines through licensed pharmaceutical wholesalers, pharmacies, hospitals and other healthcare providers. Crescent does not sell medicines directly to patients. If you have been prescribed a medicine that your pharmacy does not currently have available, your pharmacist can advise you about availability and appropriate alternatives.
You can discuss medicine availability with your pharmacist. The medicine supplied will depend on the prescription, product availability and the professional judgement of your pharmacist or prescriber.
Crescent Pharma supplies licensed pharmaceutical organisations only. If you are interested in exploring a business opportunity with Crescent Pharma within the UK, we kindly request that you visit our Customers page for more detail.
Crescent Pharma already work with several key partners across the supply chain and value the strong relationships that we have in place. We are also keen to build our outreach and supplier base. If you are interested in exploring a business opportunity with Crescent Pharma, we kindly request that you visit our Suppliers page for more detail.
Interaction information is available within the Patient Information Leaflet and Summary of Product Characteristics (SmPC). Your pharmacist or healthcare professional can also advise you.
Generic medicines contain the same active ingredient as the original branded medicine and meet the same rigorous standards of quality, safety and effectiveness.
Yes. Generic medicines must meet the same regulatory standards as branded medicines before they can be approved for use.
Medicines are manufactured under Good Manufacturing Practice (GMP) and distributed under Good Distribution Practice (GDP), with oversight from regulatory authorities including the MHRA.
https://www.gov.uk/guidance/good-manufacturing-practice-and-good-distribution-practice
GSL medicines can be sold in general retail outlets, P medicines require pharmacist supervision, and POM medicines require a valid prescription from a healthcare professional.
The Summary of Product Characteristics (SmPC) is the official regulatory document that provides healthcare professionals with prescribing and safety information for a medicine.
Branded medicines are the original medicines developed under patent protection before generic versions become available.
No. Generic versions are only available once patents expire and a generic medicine has been successfully developed and approved.
Not always. They may differ in colour, size or shape, but they contain the same active ingredient and work in the same way.
Patents allow pharmaceutical innovators to protect their investment in developing new medicines before generic competition becomes available.
If your question is not covered in our FAQs, please contact the relevant Crescent Pharma team through our Contact Us page.
Yes. Crescent Pharmaceutical Group operates multiple MHRA approved manufacturing facilities across the UK producing tablets, capsules, liquids, creams, gels and other dosage forms.
Yes. Crescent Pharma supplies medicines across the NHS, hospitals, pharmacies and healthcare providers throughout the UK while supporting reliable medicine availability.
Our medicines are manufactured through a combination of MHRA approved UK facilities and carefully selected international manufacturing partners operating to recognised GMP standards.
No. Crescent Pharma supplies licensed healthcare organisations and does not sell medicines directly to members of the public.
Every medicine is manufactured, tested and distributed in accordance with strict GMP and GDP standards, supported by robust quality assurance and regulatory oversight.
Crescent Pharma invests in UK manufacturing, multiple distribution centres, dual sourcing strategies and strategic stockholding to help maintain a reliable supply of medicines.
Yes. Crescent Pharma supplies medicines to international markets through an expanding global network supported by regulatory expertise and international partnerships.
Crescent Pharma supplies licensed pharmacies, wholesalers, hospitals, healthcare providers and approved international customers. We do not supply medicines directly to the general public.
Prospective suppliers are assessed through a qualification process that includes regulatory, quality and commercial evaluation before approval.
Medicines placed on the UK market must have the appropriate regulatory authorisation and meet applicable UK requirements. Crescent operates within the pharmaceutical regulatory framework applicable to its licensed activities and medicines.
Yes. Crescent Pharma continually invests in research, development and product launches to expand its portfolio and improve patient access to affordable medicines.
Crescent Pharma offers one of the UK’s broadest generic medicine portfolios, with hundreds of licensed products across multiple therapeutic areas and dosage forms.
Healthcare professionals can refer to the current Summary of Product Characteristics (SmPC) and other approved product information. For additional medical or scientific enquiries relating to a Crescent medicine, please contact our Medical Information team.